Paul Anderson
Gastroenterology · Plano, TXNPI 1578676664
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 48.8% of the total. Reporting peaked in 2021 at $1,789 and has fallen 99.0% since, to $18 in 2023. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 208 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$313
- Takeda Pharmaceuticals U.S.A., Inc.$192
- Gilead$175
- Ironwood Pharmaceuticals, Inc$116
- Nestle Healthcare Nutrition Inc.$110
- plus $683 from 20 others
What the payments were for
- Food & beverage$3,104100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 102 | $1,516 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $313 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $192 |
| Gilead | 11 | $175 |
| Ironwood Pharmaceuticals, Inc | 7 | $116 |
| Nestle Healthcare Nutrition Inc. | 6 | $110 |
| Merck | 5 | $85 |
| Redhill Biopharma Inc. | 4 | $68 |
| Intercept Pharmaceuticals, Inc. | 4 | $67 |
| Pfizer | 3 | $61 |
| QOL Medical, LLC | 3 | $52 |
| Braintree Laboratories, Inc. | 3 | $41 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Bristol Myers Squibb | 2 | $31 |
| Organon | 4 | $31 |
| UCB, Inc. | 2 | $31 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| Vivus LLC | 2 | $23 |
| Shire North American Group Inc | 1 | $22 |
| Amgen | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Biofire Diagnostics, LLC | 1 | $18 |
| Evoke Pharma, Inc. | 1 | $16 |
| Micro-tech Endoscopy USA, Inc. | 1 | $12 |
| Dynavax Technologies Corporation | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
How this compares
$3,104 in reported general payments places this provider in the 50th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Plano
- Brian CooleyPlano$152K
- Stuart AkermanPlano$134K
- Son DoPlano$106K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.